Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Johnson and Johnson
McKinsey
Dow

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BUPRENORPHINE HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Buprenorphine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000200 Cocaine Effects in Humans: Physiology and Behavior - 1 Completed Columbia University Phase 2 1997-01-01 The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.
NCT00000200 Cocaine Effects in Humans: Physiology and Behavior - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1997-01-01 The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1988-08-01 The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 Completed Yale University Phase 2 1988-08-01 The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Buprenorphine Hydrochloride

Condition Name

Condition Name for Buprenorphine Hydrochloride
Intervention Trials
Opioid-Related Disorders 93
Opioid Dependence 32
Heroin Dependence 30
Pain 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Buprenorphine Hydrochloride
Intervention Trials
Opioid-Related Disorders 143
Substance-Related Disorders 46
Disease 36
Heroin Dependence 33
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Buprenorphine Hydrochloride

Trials by Country

Trials by Country for Buprenorphine Hydrochloride
Location Trials
Japan 29
United Kingdom 26
Germany 10
Malaysia 7
Norway 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Buprenorphine Hydrochloride
Location Trials
New York 72
California 66
Florida 60
Pennsylvania 54
Maryland 50
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Buprenorphine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Buprenorphine Hydrochloride
Clinical Trial Phase Trials
Phase 4 63
Phase 3 94
Phase 2/Phase 3 8
[disabled in preview] 94
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Buprenorphine Hydrochloride
Clinical Trial Phase Trials
Completed 236
Recruiting 44
Not yet recruiting 39
[disabled in preview] 28
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Buprenorphine Hydrochloride

Sponsor Name

Sponsor Name for Buprenorphine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 133
Yale University 27
Purdue Pharma LP 27
[disabled in preview] 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Buprenorphine Hydrochloride
Sponsor Trials
Other 313
Industry 164
NIH 141
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Moodys
Baxter
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.